Rapid HER2 cytologic fluorescence in situ hybridization for breast cancer using noncontact alternating current electric field mixing

BACKGROUND: Human epidermal growth factor receptor 2‐in situ hybridization (HER2‐ISH) is widely approved for diagnostic, prognostic biomarker testing of formalin‐fixed paraffin‐embedded tissue blocks. However, cytologic ISH analysis has a potential advantage in tumor samples such as pleural effusion...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Watanabe, Shin‐nosuke, Imai, Kazuhiro, Nanjo, Hiroshi, Wakamatsu, Yuki, Kimura, Yoshihiko, Katayose, Yoshihisa, Kamata, Shuichi, Terata, Kaori, Takahashi, Eriko, Ibonai, Ayano, Yamaguchi, Ayuko, Konno, Hikari, Yatsuyanagi, Misako, Kudo, Chiaki, Takashima, Shinogu, Akagami, Yoichi, Nakamura, Ryuta, Sato, Yusuke, Motoyama, Satoru, Nomura, Kyoko, Minamiya, Yoshihiro
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877363/
https://ncbi.nlm.nih.gov/pubmed/33280268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars